Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,590.00
+130.00 (1.74%)
At close: Apr 28, 2026

Wonbiogen Revenue

In the year 2025, Wonbiogen had annual revenue of 35.24B KRW with 15.78% growth. Wonbiogen had revenue of 9.37B in the quarter ending December 31, 2025, with 10.15% growth.

Revenue
35.24B
Revenue Growth
+15.78%
P/S Ratio
1.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
53.77B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202535.24B4.80B15.78%
Dec 31, 202430.44B824.93M2.79%
Dec 31, 202329.61B2.87B10.72%
Dec 31, 202226.75B9.03B50.94%
Dec 31, 202117.72B5.70B47.46%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
KM Corporation 135.41B
MEDYSSEY Co.,Ltd 10.60B
SCL Science 22.01B
Billions 25.31B
Plasmapp 8.48B
JW Shinyak 81.04B
Sewoon Medical 63.66B
OSTEONIC 45.39B
Revenue Rankings